Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 studyRichard Fox, Daniel H. Palmer, Hassan Malik et al.|The Lancet Oncology|2019Cited by 1.2k
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trialHugo Ford, Janet Dunn, Andrea Marshall et al.|The Lancet Oncology|2013Cited by 604
Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic CholangiocarcinomaLipika Goyal, John Bridgewater, Funda Meric‐Bernstam et al.|New England Journal of Medicine|2023Cited by 530
A DNA methylation fingerprint of 1628 human samplesAgustín F. Fernández, Manel Esteller, Xabier Agirre et al.|Genome Research|2011Cited by 418
Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trialsJuan W. Valle, Takuji Okusaka, Junji Furuse et al.|Annals of Oncology|2013Cited by 395